Please login below, for login help 
A reliable investment strategy: Identify a widely diversified portfolio of high-quality stocks and build up additional holdings at favorable prices.
DRIPs can help you do that.
Even small investors can follow such a strategy by investing through dividend reinvestment plans (DRIPs). That's because it takes ownership of only a single share of company stock to establish an account. Therefore, there is nothing to stop you from buying companies in a variety of industries.
As for buying at favorable prices, dollar-cost averaging virtually assures that you will buy most shares at favorable prices. And DRIPs provide an excellent way to dollar-cost average. These plans allow you to invest cash amounts to buy shares directly from the company. Once you are enrolled in a plan, you can invest amounts of as little as $25 or $50 (or as much as you can afford) to buy shares or fractions of shares. That's different than the traditional way to invest, which is to pay brokerage fees to buy a certain number of shares.
Johnson & Johnson (JNJ)
Available from the Temper Enrollment Service: Yes
Last Update On: 01/22/2020:
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand oral care products under the LISTERINE brand beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, and OGX brands over-the-counter medicines, including acetaminophen products under the TYLENOL brand cold, flu, and allergy products under the SUDAFED brand allergy products under the BENADRYL and ZYRTEC brands ibuprofen products under the MOTRIN IB brand and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands wound care products comprising adhesive bandages under the BAND-AID brand and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides orthopedic products general surgery, biosurgical, endomechanical, and energy products electrophysiology products to treat cardiovascular diseases sterilization and disinfection products to reduce surgical infection diabetes care products and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. It has research and collaboration alliance with Morphic Therapeutic. The company was incorporated in 1887 and is based in New Brunswick, New Jersey. **Taken from Yahoo Finance**
| Industry: | Health care & consumer products |
| Minimum Investment: | $25.00 |
| Maximum Investment: | 50,000/year |
| Shares to qualify: | 1 |
| Recent Price: | 133.01 |
| Investing Fee: | $0.00 |
| Fee for Dividends: | $0! |
! = Company pays fees
Information is based on an annual survey and updated when company changes become available.